TLRY

4.03

3.87% 0.15

Dopo l'orario di chiusura: 4.04 0.010 +0.25%

Tilray Brands Inc (TLRY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TLRY Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$3.88

Aprire:

$3.91

Volume 24 ore:

3.59M

Relative Volume:

0.75

Capitalizzazione di mercato:

$497.53M

Reddito:

$858.28M

Utile/perdita netta:

$-1.34B

Rapporto P/E:

-0.295

EPS:

-13.6608

Flusso di cassa netto:

$-75.96M

1 W Prestazione:

-4.73%

1M Prestazione:

-13.15%

6M Prestazione:

-52.14%

1 anno Prestazione:

-41.47%

Intervallo 1D:

$3.91

$4.08

Intervallo di 1 settimana:

$3.80

$4.32

Portata 52W:

$3.80

$23.20

Tilray Brands Inc Stock (TLRY) Company Profile

Nome

Tilray Brands Inc

Settore

Healthcare (1074)

Industria

Drug Manufacturers - Specialty & Generic (87)

Telefono

519.322.8800

Indirizzo

655 MADISON AVENUE, NEW YORK

Dipendente

2,842

Cinguettio

@tilray

Prossima data di guadagno

2026-07-28

Ultimi documenti SEC

TLRY's Discussions on Twitter

Compare TLRY vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TLRY Tilray Brands Inc	4.03	479.01M	858.28M	-1.34B	-75.96M	-13.66
TAK Takeda Pharmaceutical Co Adr	17.44	55.06B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.94	43.07B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.08	35.88B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.92	31.59B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	527.94	26.32B	3.17B	1.29B	1.01B	27.09

Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-02	Aggiornamento	Roth Capital	Neutral → Buy
2026-01-27	Iniziato	Canaccord Genuity	Hold
2024-04-05	Reiterato	Alliance Global Partners	Neutral
2022-11-02	Iniziato	Bernstein	Mkt Perform
2022-07-29	Downgrade	The Benchmark Company	Hold → Sell
2022-03-04	Aggiornamento	Canaccord Genuity	Hold → Buy
2021-11-18	Iniziato	Barclays	Underweight
2021-11-01	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2021-06-11	Downgrade	CIBC	Sector Outperform → Neutral
2021-06-03	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2021-05-11	Ripresa	Cowen	Outperform
2021-05-07	Ripresa	Jefferies	Buy
2021-05-06	Iniziato	Canaccord Genuity	Buy
2021-04-28	Ripresa	BofA Securities	Buy
2021-02-18	Downgrade	Piper Sandler	Overweight → Neutral
2021-02-18	Downgrade	The Benchmark Company	Buy → Hold
2020-11-16	Downgrade	Jefferies	Hold → Underperform
2020-11-11	Downgrade	Stifel	Hold → Sell
2020-10-01	Reiterato	MKM Partners	Neutral
2020-09-21	Aggiornamento	Jefferies	Underperform → Hold
2020-05-12	Reiterato	The Benchmark Company	Buy
2020-04-16	Downgrade	Jefferies	Hold → Underperform
2020-04-09	Downgrade	Consumer Edge Research	Overweight → Equal Weight
2020-02-24	Downgrade	Cowen	Outperform → Market Perform
2020-01-13	Iniziato	BofA/Merrill	Neutral
2019-11-13	Reiterato	The Benchmark Company	Buy
2019-11-05	Iniziato	Cantor Fitzgerald	Neutral
2019-10-22	Reiterato	Piper Jaffray	Overweight
2019-09-20	Iniziato	MKM Partners	Neutral
2019-08-14	Reiterato	The Benchmark Company	Buy
2019-07-17	Iniziato	Ladenburg Thalmann	Neutral
2019-06-28	Iniziato	Consumer Edge Research	Overweight
2019-06-06	Iniziato	Stifel	Hold
2019-06-05	Iniziato	Oppenheimer	Perform
2019-05-15	Aggiornamento	BMO Capital Markets	Underperform → Market Perform
2019-05-13	Iniziato	Alliance Global Partners	Neutral

Mostra tutto

Tilray Brands Inc Borsa (TLRY) Ultime notizie

12:18 PM

Tilray Stock Eyes Breakout Week: Trump’s Cannabis Order Opens Door To US Cancer Market Entry - Stocktwits

Jul 25, 2026